Optibiotix Health Share Discussion Threads

[parob] 22/12/2016 10:46

Interestingly Kipper, something I spotted the other day, Graeme Karavis, the MD UK&I at Tata Global Beverages, previously worked at Premier Foods, at the same time as our very own Jim Laird. Coincidence?

[kipper1960] 22/12/2016 10:35

Pure speculation, this. The last news was about partnering with an Asian based MN to develop a range of Slimbiome based products and news on the street is the MN is Tata Group. SOH subsequently hinted in interviews that there was possibilities of other deals with the same MN.

Tata has a subsidiary called Tata Global Beverages whose mission is "to become a global leader in branded ‘good for you’ beverages through innovation, strategic acquisition and organic growth".

Sweetbiotix??

[primal123] 22/12/2016 10:07

Can you tell us who gave that reply JH? I am struggling to see how they could even say that.

[tightfist] 22/12/2016 09:36

I am a real believer in the mid/long term potential if OPTI, but is it going to hold this 62p level....Hopefully it will get chosen somewhere influential as a 2017 Tip!

[scotty1] 22/12/2016 08:57

JH how could the "interesting response" make you "be adding once again" they obviously
cannot tell you anything that isn't already in the public domain.

[judijudi] 22/12/2016 08:39

I would have thought from the last few RNS's that its blatantly obvious that they will be in a closed period!

[john henry] 22/12/2016 08:29

Good thinking Raf

[rafboy] 22/12/2016 08:25

It may be that JH is suggesting the directors cannot buy as they are in a closed period. This could mean that a deal may be announced soon. This is just a guess.

[sukithedog] 22/12/2016 08:05

Close period???

[john henry] 22/12/2016 08:00

Close period

[judijudi] 22/12/2016 07:59

JH,
Your up n down like a bloody Yo Yo
Chill your boots

[primal123] 22/12/2016 00:55

Can you tell us what was said JH?

[1bokke] 22/12/2016 00:44

JH could you provide some context to your last post please, otherwise it just looks like multiple personalities sitting in front a screen?? It's a winner, no it isn't. It's a winner, no it isn't.....

[john henry] 22/12/2016 00:27

Well I've had a very interesting response from the company, having expressed further concerns.All I can say I will be adding once again.

[parob] 21/12/2016 23:17

Why OPTI's patents will be worth their weight in gold:

Danone fails in prebiotic infant microbiome patent challenge
21-Dec-2016

French dairy and probiotics giant Danone has failed to shut down an infant microbiome-focused prebiotic composition patent, after a European Patent Office (EPO) ruling.

[warren1982] 21/12/2016 22:23

Hold the line, stay the course, ignore the Bull-------s and you will be well rewarded, I have been holding these share's since just after launch sitting on a very nice profit. I don't have any doubt whatsoever that SOH will deliver, lets see what the trolls have to say in December 2017 it sure won't be below £1.00.
GLA.

[primal123] 21/12/2016 22:13

Agreed Parob, JH you blow so hot and cold it's unbelievable, only a few days ago you were saying how confident you were and now you have changed your tune totally.Nothing has changed here, share price has been disappointing but I am positive this will change soon.

[judijudi] 21/12/2016 21:08

Your in profit. Your not trapped in
Move on
Quite simple really

[john henry] 21/12/2016 20:57

The company has experienced almost two years of continuous Institutional selling and very little institutional buying. That to me. doesn't invoke confidence.

[judijudi] 21/12/2016 20:21

Great for us guys who see the big picture. Keep mopping up when funds and the price allow
2017 transformational
imho

[mazzstar] 21/12/2016 19:28

Without hard numbers the market will cease to care about any 'potential' here. I will not be surprised if this goes to 40p next year which is why I've increased my stop loss to 50p so that I can get out with at least some semblance of an investment. What a poor poor show it's been this year and I hope the latest 'agreement' is not a sign of deals to come in 2017 with the same vague RNS's, lack of any numbers and ZERO upfront payments.

[whl2] 21/12/2016 19:13

You too elrico - see you next year

[riskybusiness1] 21/12/2016 18:48

It's because of lack of commercial ££'s. I don't believe last years pump has helped but I believe that to be more from tw camp than of the companies. This science opti are using is pharmaceutical spec but able to bring this tech to market quicker due to less regulations. It also de risks the science using much less investment. Imagine opti being in seres health position now with their lead candidate seres 109 in huge trouble. But opti is sitting here with all platforms performing better than expected opening up more opportunities. I also believe the market underestimates the time it takes to bring a concept through to commercial. Not helped by tw stating last year 'months away from deal with png' a month following early clinical trial results. Look at the competitors and you realise how unfairly impatient the market is on opti currently

[elrico] 21/12/2016 18:43

Right, I'm really signing off for Christmas before I end up reaching for the Valium.Have a good one people.